Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis

BACKGROUND: Current therapeutic options for atopic dermatitis (AD) are limited. Janus kinase (JAK) inhibitors may be viable alternatives. OBJECTIVES: To assess the efficacy and safety of JAK inhibitors for AD treatment. METHODS: We searched PubMed, Embase, the Cochrane Controlled Register of Trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenyang, Sun, Xun, Zhao, Kun, Meng, Fanxiang, Li, Lin, Mu, Zhenzhen, Han, Xiuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Atopic Dermatitis − Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393843/
https://www.ncbi.nlm.nih.gov/pubmed/34455413
http://dx.doi.org/10.1159/000518541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393843/
https://www.ncbi.nlm.nih.gov/pubmed/34455413
http://dx.doi.org/10.1159/000518541

Ejemplares similares